Search Results - "NEEF, C"

Refine Results
  1. 1

    Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs by van Leeuwen, R W F, Brundel, D H S, Neef, C, van Gelder, T, Mathijssen, R H J, Burger, D M, Jansman, F G A

    Published in British journal of cancer (19-03-2013)
    “…Background: Potential drug–drug interactions (PDDIs) in patients with cancer are common, but have not previously been quantified for oral anticancer treatment…”
    Get full text
    Journal Article
  2. 2

    Anisotropic ionic conductivity of LiMn1−xFexPO4 (0 ≤ x ≤ 1) single crystals by Neef, C., Reiser, A., Thauer, E., Klingeler, R.

    Published in Solid state ionics (01-03-2020)
    “…We report AC-impedance studies on a series of high-quality LiMn1−xFexPO4 single crystals with 0 ≤ x ≤ 1. Our results confirm quasi-one-dimensional transport in…”
    Get full text
    Journal Article
  3. 3

    Population pharmacokinetics of unbound ceftriaxone in a critically ill population by Meenks, Sjoerd D., Noble, Jos L.M.L. le, Foudraine, Norbert A., Vries, Frank de, Neef), Kees Neef (C., Janssen, Paddy K.C.

    “…Objective: To develop a reliable 2-compartment population pharmacokinetic (PK) model for unbound ceftriaxone in a critically ill population and determine an…”
    Get full text
    Journal Article
  4. 4

    Meta‐analysis: rapid infliximab infusions are safe by Neef, H. C., Riebschleger, M. P., Adler, J.

    Published in Alimentary pharmacology & therapeutics (01-08-2013)
    “…Summary Background Infliximab is typically administered intravenously via 2‐ to 3‐h duration infusions. Infusions are time‐consuming and costly. Shorter…”
    Get full text
    Journal Article
  5. 5

    Synthesis and magnetism of a Li2FeSiO4 single crystal by Hergett, W., Jonak, M., Werner, J., Billert, F., Sauerland, S., Koo, C., Neef, C., Klingeler, R.

    “…•High-pressure optical floating-zone Single crystal growth of Li2FeSiO4 is reported.•Sharp transition to antiferromagnetic order at TN=17.0(5)K.•Broad maximum…”
    Get full text
    Journal Article
  6. 6

    Use of incretin agents and risk of pancreatic cancer: a population-based cohort study by Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., Driessen, J. H. M.

    Published in Diabetes, obesity & metabolism (01-03-2016)
    “…Aim To investigate the association between the use of incretin agents and the risk of pancreatic cancer. Methods A retrospective population‐based cohort study,…”
    Get full text
    Journal Article
  7. 7

    Risk of fracture in patients with Parkinson’s disease by Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E. J, Neef, C., Cooper, C., de Vries, F.

    Published in Osteoporosis international (01-08-2013)
    “…Summary The aim of the study was to determine fracture risk in incident Parkinson’s disease (PD) patients. This study showed that fracture risk assessment may…”
    Get full text
    Journal Article
  8. 8

    Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial by Arbouw, M E L, Movig, K L L, Koopmann, M, Poels, P J E, Guchelaar, H-J, Egberts, T C G, Neef, C, van Vugt, J P P

    Published in Neurology (13-04-2010)
    “…Sialorrhea affects approximately 75% of patients with Parkinson disease (PD). Sialorrhea is often treated with anticholinergics, but central side effects limit…”
    Get full text
    Journal Article
  9. 9

    MEH-PPV:  Improved Synthetic Procedure and Molecular Weight Control by Neef, C. J, Ferraris, J. P

    Published in Macromolecules (04-04-2000)
    “…Mechanistic studies on the polymerization of α,α‘-dibromo-2-methoxy-5-(2-ethylhexyloxy)xylene have been performed. Polymerizations were initially carried out…”
    Get full text
    Journal Article
  10. 10

    Five-year fracture risk estimation in patients with Parkinson's disease by Pouwels, Sander, Bazelier, Marloes T, de Boer, Anthonius, Weber, Wim E.J, Neef, C. (Kees), Cooper, Cyrus, de Vries, Frank

    Published in Bone (New York, N.Y.) (01-10-2013)
    “…Abstract Background Previous studies have shown that patients with Parkinson's disease (PD) are at increased risk of fractures. However, no specific prediction…”
    Get full text
    Journal Article
  11. 11

    Interchangeability of Gabapentin Generic Formulations in the Netherlands: A Comparative Bioavailability Study by Yu, Y, Teerenstra, S, Vanmolkot, F, Neef, C, Burger, D, Maliepaard, M

    Published in Clinical pharmacology and therapeutics (01-10-2013)
    “…To investigate the so‐called “drift” with generic–generic drug substitution, a single‐dose, four‐way crossover comparative bioavailability study was performed…”
    Get full text
    Journal Article
  12. 12

    Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometry by van der Heijden, J., de Beer, Y., Hoogtanders, K., Christiaans, M., de Jong, G.J., Neef, C., Stolk, L.

    “…An assay of everolimus based on finger prick sampling and consecutive application as a blood spot on sampling paper has been developed. We explored several…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Robustness of the Conclusion of Bioequivalence; A Non-Parametric Comparison by Glerum, P.J, Yu, Y, Yamada, W, Neely, M, Maliepaard, M, Burger, D, Neef, C

    Published in Clinical therapeutics (01-08-2017)
    “…Methods Data was gathered in a 4-way crossover study in 24 subjects with 4 different oral formulations of gabapentin previously concluded to be bioequivalent…”
    Get full text
    Journal Article
  14. 14

    Cost-effectiveness of therapeutic drug monitoring: a systematic review by Touw, D J, Neef, C, Thomson, A H, Vinks, A A

    Published in Therapeutic drug monitoring (01-02-2005)
    “…There are a number of effective but highly toxic drugs that exhibit a narrow therapeutic index and marked interpatient pharmacokinetic variability…”
    Get full text
    Journal Article
  15. 15

    Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms by WIJNEN, P. A. H. M., OP DEN BUIJSCH, R. A. M., DRENT, M., KUIPERS, P. M. J. C., NEEF, C., BAST, A., BEKERS, O., KOEK, G. H.

    Published in Alimentary pharmacology & therapeutics (01-12-2007)
    “…Summary Background  Most drugs currently used in clinical practice are effective in only 25% to 60% of patients, while adverse drug reactions (ADRs) as a…”
    Get full text
    Journal Article Conference Proceeding
  16. 16
  17. 17

    Multiple intravenous doses of paracetamol result in a predictable pharmacokinetic profile in very preterm infants by van Ganzewinkel, C, Derijks, L, Anand, KJS, van Lingen, RA, Neef, C, Kramer, BW, Andriessen, P

    Published in Acta Paediatrica (01-06-2014)
    “…Aim The therapeutic options available to treat neonatal pain are limited, and one alternative for nonopioid systemic treatment is paracetamol. However,…”
    Get full text
    Journal Article
  18. 18

    Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring by Kerkhofs, T M A, Derijks, L J J, Ettaieb, M H T, Eekhoff, E M W, Neef, C, Gelderblom, H, den Hartigh, J, Guchelaar, H J, Haak, H R

    Published in European journal of endocrinology (01-12-2014)
    “…ObjectiveMitotane is the drug of choice in patients with adrenocortical carcinoma. The anti-neoplastic effect is correlated with mitotane plasma levels, which…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution by Scheepers, H PA, Langedijk, J, Neerup Handlos, V, Walser, S, Schutjens, M H, Neef, C

    “…IntroductionThe rights of patients should be sufficiently protected even when an appropriate authorised medicine does not exist or is unavailable on the…”
    Get full text
    Journal Article